Ochre Bio is a biotechnology company dedicated to developing innovative RNA therapies aimed at addressing chronic liver diseases. Through cutting-edge genomic deep phenotyping and in vivo testing, they strive to enhance liver health by tackling significant challenges associated with donor liver supply and cirrhosis complications.